Royal Bank Of Canada Eagle Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 36,925 shares of EGRX stock, worth $19,201. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,925

Previous 37,601 1.8%

Holding current value

$19,201

Previous $210,000 35.24%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.71 - $6.07 $2,507 - $4,103	-676 Reduced 1.8%	36,925 $136,000
Q2 2024 Aug 14, 2024	BUY	$3.34 - $5.6 $31,546 - $52,892	9,445 Added 33.55%	37,601 $210,000
Q1 2024 Nov 05, 2024	SELL	$4.26 - $6.51 $40,235 - $61,486	-9,445 Reduced 25.12%	28,156 $147,000
Q1 2024 May 15, 2024	BUY	$4.26 - $6.51 $104,796 - $160,146	24,600 Added 691.79%	28,156 $147,000
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $7,843 - $25,765	1,694 Added 90.98%	3,556 $18,000
Q3 2023 Nov 14, 2023	SELL	$15.21 - $22.88 $24,974 - $37,568	-1,642 Reduced 46.86%	1,862 $29,000
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $27,284 - $49,016	-1,538 Reduced 30.5%	3,504 $68,000
Q1 2023 May 15, 2023	BUY	$25.06 - $34.09 $53,102 - $72,236	2,119 Added 72.49%	5,042 $143,000
Q4 2022 Feb 14, 2023	SELL	$24.98 - $39.77 $10,616 - $16,902	-425 Reduced 12.69%	2,923 $85,000
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $83,223 - $148,428	3,150 Added 1590.91%	3,348 $88,000
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $26,984 - $33,582	-654 Reduced 76.76%	198 $9,000
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $54,253 - $64,014	-1,217 Reduced 58.82%	852 $42,000
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $42,612 - $52,917	930 Added 81.65%	2,069 $106,000
Q3 2021 Nov 15, 2021	SELL	$43.79 - $55.78 $205,637 - $261,942	-4,696 Reduced 80.48%	1,139 $64,000
Q2 2021 Aug 16, 2021	BUY	$36.86 - $44.5 $215,078 - $259,657	5,835 New	5,835 $250,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $6.77M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Eagle Pharmaceuticals, Inc. Transaction History